Mohamed Saleh Elgawish

11PUBLICATIONS
14CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)PharmacogenomicsPsychosocial aspects of childbirth and perinatal mental healthCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 08, 2025
Leveraging artificial intelligence and machine learning in kinase inhibitor development: advances, challenges, and future prospects.

Mohamed S Elgawish, Aya M Almatary, Sawsan A Zaitone

|Apr 17, 2025
Revealing Pharmacokinetic Interactions of Tramadol, Tapentadol, and Venlafaxine: A Cutting-Edge Liquid Chromatography-Tandem Mass Spectrometry Analytical Approach in Rat Plasma.

Hala M Heneedak, Khaled M Darwish, Samia M Mostafa

|Dec 19, 2024
Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Citalopram and Duloxetine: An Integrated Analytical, Computational, Behavioral, and Biochemical Approach.

Mohamed S Elgawish, Asmaa M Atta, Sameh M Hafeez

|Apr 29, 2024
Unveiling Pharmacokinetics and Drug Interaction of Linagliptin and Pioglitazone HCl in Rat Plasma Using LC-MS/MS.

Heba Aref, Sherin Hammad, Khaled M Darwish

|Nov 22, 2023
Novel fluorescence approach for trace quantification of levonorgestrel in breast milk based on click reaction with benzonitrofurazan azide (NBD-AZ).

Heba A Aref, Ismail Salama, Shaimaa Mohamed Aboukhatwa

|Mar 31, 2023
2-Phenylquinazolin-4(3H)-one scaffold as newly designed, synthesized VEGFR-2 allosteric inhibitors with potent cytotoxicity through apoptosis.

Ranza Elrayess, Mohamed S Elgawish, Mohamed S Nafie

Pageof 2

Frequent Collaborators

2 joint publications

Sameh S Elhady

2 joint publications

Mohamed S Nafie

2 joint publications

Ranza Elrayess

2 joint publications

Asmaa S A Yassen